US Stock MarketDetailed Quotes

CUE Cue Biopharma

Watchlist

1.020
-0.010-0.97%

Close Nov 22 16:00 ET

1.000
-0.020-1.96%

Pre 08:00 ET

64.62MMarket Cap-1120P/E (TTM)

Cue Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

3.49%-7.53M

3.67%-9.99M

9.68%-9.78M

4.41%-39.96M

-4.22%-10.96M

-13.51%-7.8M

19.28%-10.37M

6.39%-10.83M

-7.64%-41.81M

1.23%-10.51M

Net income from continuing operations

21.31%-8.66M

22.86%-10.17M

5.81%-12.35M

4.30%-50.73M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-20.04%-53.01M

-74.04%-14.59M

Operating gains losses

---98K

----

3,825.00%157K

-38.37%159K

--0

---2K

118.56%4K

47,009.09%258K

Depreciation and amortization

2.45%877K

1.53%862K

-3.52%849K

90.25%3.44M

46.72%851K

58.81%856K

85.37%849K

284.28%880K

201.58%1.81M

109.46%580K

Other non cash items

0.00%43K

0.00%41K

0.00%42K

221.90%167K

117.52%41K

2.38%43K

-21.15%41K

1,300.00%42K

---137K

---234K

Change In working capital

-617.07%-1.27M

-6,095.00%-2.48M

44.42%-274K

-362.36%-934K

-140.90%-647K

-84.03%246K

98.19%-40K

12.12%-493K

108.11%356K

76.65%1.58M

-Change in receivables

-148.10%-1.31M

52.35%-447K

314.39%298K

-153.19%-1.64M

-105.15%-38K

-776.67%-526K

-596.30%-938K

-106.27%-139K

278.84%3.09M

131.13%738K

-Change in prepaid assets

-54.42%340K

-51.79%216K

27.63%-998K

106.93%25K

-76.14%210K

-32.30%746K

134.38%448K

-32.60%-1.38M

-81.45%-361K

23.07%880K

-Change in payables and accrued expense

1.86%1.2M

-145.85%-658K

215.52%1.49M

237.45%1.36M

-89.74%31K

48.55%1.18M

260.16%1.44M

-8.41%-1.29M

-141.99%-988K

-59.79%302K

-Change in other current liabilities

-11.69%-793K

-10.40%-775K

-13.65%-741K

-279.32%-2.79M

-114.20%-724K

-139.06%-710K

-260.00%-702K

-786.32%-652K

-125.29%-735K

-105.27%-338K

-Change in other working capital

-61.12%-717K

-187.63%-814K

-110.86%-322K

427.44%2.11M

---126K

---445K

---283K

559.84%2.97M

91.91%-645K

--0

Cash from discontinued investing activities

Operating cash flow

3.49%-7.53M

3.67%-9.99M

9.68%-9.78M

4.41%-39.96M

-4.22%-10.96M

-13.51%-7.8M

19.28%-10.37M

6.39%-10.83M

-7.64%-41.81M

1.23%-10.51M

Investing cash flow

Cash flow from continuing investing activities

-98.04%98K

-100.20%-10K

-100.37%-55K

201.59%25M

116.94%5M

8,164.52%5M

55,662.96%15M

-370.19%-24.61M

978,177.89%5M

Net PPE purchase and sale

--98K

---10K

-2,850.00%-55K

101.21%2K

--0

107.41%2K

81.49%-165K

-295.69%-1K

Net investment purchase and sale

--0

202.27%25M

--0

116.98%5M

--5M

--15M

-344.45%-24.45M

--5M

Cash from discontinued investing activities

Investing cash flow

-98.04%98K

-100.20%-10K

-100.37%-55K

201.59%25M

--0

116.94%5M

8,164.52%5M

55,662.96%15M

-370.19%-24.61M

978,177.89%5M

Financing cash flow

Cash flow from continuing financing activities

114.01%9.82M

-147.60%-1M

506.70%2.35M

-77.90%11.86M

-82.55%4.78M

51,088.89%4.59M

-81.09%2.1M

-97.44%388K

178.99%53.66M

271.20%27.4M

Net issuance payments of debt

0.00%-1M

---1M

-120.00%-2M

---1M

--0

--10M

--0

Net common stock issuance

93.61%10.82M

--0

--3.35M

-65.94%13.39M

-74.53%5.78M

--5.59M

-81.85%2.02M

--0

126.06%39.3M

223.04%22.7M

Proceeds from stock option exercised by employees

--0

-89.94%473K

--0

--85K

--388K

80.85%4.7M

773.96%4.7M

Net other financing activities

----

54.54%-341K

100.55%1K

Cash from discontinued financing activities

Financing cash flow

114.01%9.82M

-147.60%-1M

506.70%2.35M

-77.90%11.86M

-82.55%4.78M

51,088.89%4.59M

-81.09%2.1M

-97.44%388K

178.99%53.66M

271.20%27.4M

Net cash flow

Beginning cash position

-43.11%30.18M

-26.88%41.18M

-5.99%48.67M

-19.77%51.76M

83.56%54.84M

-19.95%53.05M

-17.27%56.32M

-19.77%51.76M

-13.99%64.52M

-55.92%29.88M

Current changes in cash

33.63%2.39M

-236.39%-11M

-264.25%-7.49M

75.71%-3.1M

-128.22%-6.18M

104.92%1.79M

-81.57%-3.27M

28.15%4.56M

-21.55%-12.76M

770.93%21.89M

End cash Position

-40.61%32.57M

-43.11%30.18M

-26.88%41.18M

-5.99%48.67M

83.56%54.84M

-19.95%53.05M

-17.27%56.32M

-19.77%51.76M

Free cash flow

3.50%-7.53M

3.58%-10M

9.18%-9.84M

4.80%-39.96M

-4.21%-10.96M

-12.23%-7.8M

19.69%-10.37M

6.61%-10.83M

-5.60%-41.98M

1.22%-10.52M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	3.49%-7.53M	3.67%-9.99M	9.68%-9.78M	4.41%-39.96M	-4.22%-10.96M	-13.51%-7.8M	19.28%-10.37M	6.39%-10.83M	-7.64%-41.81M	1.23%-10.51M
Net income from continuing operations	21.31%-8.66M	22.86%-10.17M	5.81%-12.35M	4.30%-50.73M	7.94%-13.43M	-0.46%-11.01M	0.17%-13.19M	8.04%-13.11M	-20.04%-53.01M	-74.04%-14.59M
Operating gains losses	---98K	----	----	3,825.00%157K	-38.37%159K	--0	--0	---2K	118.56%4K	47,009.09%258K
Depreciation and amortization	2.45%877K	1.53%862K	-3.52%849K	90.25%3.44M	46.72%851K	58.81%856K	85.37%849K	284.28%880K	201.58%1.81M	109.46%580K
Other non cash items	0.00%43K	0.00%41K	0.00%42K	221.90%167K	117.52%41K	2.38%43K	-21.15%41K	1,300.00%42K	---137K	---234K
Change In working capital	-617.07%-1.27M	-6,095.00%-2.48M	44.42%-274K	-362.36%-934K	-140.90%-647K	-84.03%246K	98.19%-40K	12.12%-493K	108.11%356K	76.65%1.58M
-Change in receivables	-148.10%-1.31M	52.35%-447K	314.39%298K	-153.19%-1.64M	-105.15%-38K	-776.67%-526K	-596.30%-938K	-106.27%-139K	278.84%3.09M	131.13%738K
-Change in prepaid assets	-54.42%340K	-51.79%216K	27.63%-998K	106.93%25K	-76.14%210K	-32.30%746K	134.38%448K	-32.60%-1.38M	-81.45%-361K	23.07%880K
-Change in payables and accrued expense	1.86%1.2M	-145.85%-658K	215.52%1.49M	237.45%1.36M	-89.74%31K	48.55%1.18M	260.16%1.44M	-8.41%-1.29M	-141.99%-988K	-59.79%302K
-Change in other current liabilities	-11.69%-793K	-10.40%-775K	-13.65%-741K	-279.32%-2.79M	-114.20%-724K	-139.06%-710K	-260.00%-702K	-786.32%-652K	-125.29%-735K	-105.27%-338K
-Change in other working capital	-61.12%-717K	-187.63%-814K	-110.86%-322K	427.44%2.11M	---126K	---445K	---283K	559.84%2.97M	91.91%-645K	--0
Cash from discontinued investing activities
Operating cash flow	3.49%-7.53M	3.67%-9.99M	9.68%-9.78M	4.41%-39.96M	-4.22%-10.96M	-13.51%-7.8M	19.28%-10.37M	6.39%-10.83M	-7.64%-41.81M	1.23%-10.51M
Investing cash flow
Cash flow from continuing investing activities	-98.04%98K	-100.20%-10K	-100.37%-55K	201.59%25M	0	116.94%5M	8,164.52%5M	55,662.96%15M	-370.19%-24.61M	978,177.89%5M
Net PPE purchase and sale	--98K	---10K	-2,850.00%-55K	101.21%2K	--0	--0	--0	107.41%2K	81.49%-165K	-295.69%-1K
Net investment purchase and sale	--0	--0	--0	202.27%25M	--0	116.98%5M	--5M	--15M	-344.45%-24.45M	--5M
Cash from discontinued investing activities
Investing cash flow	-98.04%98K	-100.20%-10K	-100.37%-55K	201.59%25M	--0	116.94%5M	8,164.52%5M	55,662.96%15M	-370.19%-24.61M	978,177.89%5M
Financing cash flow
Cash flow from continuing financing activities	114.01%9.82M	-147.60%-1M	506.70%2.35M	-77.90%11.86M	-82.55%4.78M	51,088.89%4.59M	-81.09%2.1M	-97.44%388K	178.99%53.66M	271.20%27.4M
Net issuance payments of debt	0.00%-1M	---1M	---1M	-120.00%-2M	---1M	---1M	--0	--0	--10M	--0
Net common stock issuance	93.61%10.82M	--0	--3.35M	-65.94%13.39M	-74.53%5.78M	--5.59M	-81.85%2.02M	--0	126.06%39.3M	223.04%22.7M
Proceeds from stock option exercised by employees	--0	--0	--0	-89.94%473K	--0	--0	--85K	--388K	80.85%4.7M	773.96%4.7M
Net other financing activities	----	----	----	----	----	----	----	----	54.54%-341K	100.55%1K
Cash from discontinued financing activities
Financing cash flow	114.01%9.82M	-147.60%-1M	506.70%2.35M	-77.90%11.86M	-82.55%4.78M	51,088.89%4.59M	-81.09%2.1M	-97.44%388K	178.99%53.66M	271.20%27.4M
Net cash flow
Beginning cash position	-43.11%30.18M	-26.88%41.18M	-5.99%48.67M	-19.77%51.76M	83.56%54.84M	-19.95%53.05M	-17.27%56.32M	-19.77%51.76M	-13.99%64.52M	-55.92%29.88M
Current changes in cash	33.63%2.39M	-236.39%-11M	-264.25%-7.49M	75.71%-3.1M	-128.22%-6.18M	104.92%1.79M	-81.57%-3.27M	28.15%4.56M	-21.55%-12.76M	770.93%21.89M
End cash Position	-40.61%32.57M	-43.11%30.18M	-26.88%41.18M	-5.99%48.67M	-5.99%48.67M	83.56%54.84M	-19.95%53.05M	-17.27%56.32M	-19.77%51.76M	-19.77%51.76M
Free cash flow	3.50%-7.53M	3.58%-10M	9.18%-9.84M	4.80%-39.96M	-4.21%-10.96M	-12.23%-7.8M	19.69%-10.37M	6.61%-10.83M	-5.60%-41.98M	1.22%-10.52M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data